Related Experiment Video
Updated: Sep 3, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Preliminary Evidence on Pulmonary Function after Asymptomatic and Mild COVID-19 in Children
Costanza Di Chiara1, Silvia Carraro2, Stefania Zanconato2
1Division of Pediatric Infectious Diseases, Department of Women's and Children's Health, University of Padua, 35128 Padua, Italy.
Insights
Children infected with the coronavirus disease 2019 (COVID-19) did not experience long-term lung problems or respiratory symptoms after mild infections. This study followed pediatric patients for up to 10 months post-infection.
Area of Science:
- Pediatric Pulmonology
- Infectious Diseases
- Respiratory Medicine
Background:
- Limited data exist on the long-term pulmonary effects of SARS-CoV-2 in children.
- Adults can experience persistent pulmonary function decline after COVID-19, regardless of initial severity.
Purpose of the Study:
- To evaluate the long-term pneumological impact of asymptomatic or mild SARS-CoV-2 infection in children.
- To assess for chronic respiratory symptoms and lung function impairment in pediatric COVID-19 survivors.
Main Methods:
- A single-center, prospective, observational study was conducted.
- 61 children aged 6-18 years with a history of asymptomatic/mild COVID-19 were included.
- Pulmonary function was assessed using spirometry approximately 10 months post-infection.
Main Results:
- No children reported respiratory symptoms at follow-up.
- No participants required inhaled respiratory therapies.
- All children demonstrated normal lung function on spirometry.
Conclusions:
- Asymptomatic or mild SARS-CoV-2 infection in children and adolescents does not appear to lead to chronic respiratory symptoms.
- Pediatric patients in this cohort did not exhibit lung function impairment following mild COVID-19.
- The long-term respiratory outlook for children with mild COVID-19 appears favorable.
Background:
While it has been described that adults can develop long-lasting deterioration in pulmonary function (PF) after coronavirus disease 19 (COVID-19), regardless of disease severity, data on the long-term pneumological impact of SARS-CoV-2 infection in children are lacking.
Methods:
Performing a single-center, prospective, observational study on children aged 6-18 years with a previous diagnosis of asymptomatic/mild COVID-19, we evaluated the long-term impact of mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children.
Results:
A total of 61 subjects underwent spirometry after a mean time of 10 ± 4 months from asymptomatic or mild infection. None of the children reported any respiratory symptoms, needed any inhaled therapy, or had abnormal lung function.
Conclusions:
In our study, we observed that children and adolescents did not develop chronic respiratory symptoms and did not present lung function impairment after asymptomatic or mild SARS-CoV-2 infection.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Pulmonary Cycle: Exhalation

